Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
NCT02598466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69
Last updated 2016-02-08
Summary
Research question: what are the patterns of patient-reported changes in physical function among adult patients using SC abatacept with moderate to severe RA since commencement of the compassionate use program (CUP).
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Hexor, South Africa
collaborator OTHER - lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
More Related Trials
-
Abatacept Versus Adalimumab Head-to-Head
NCT00929864 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT01142726 ·Status: COMPLETED ·Phase: PHASE3
-
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
NCT02037737 ·Status: COMPLETED
-
Phase IIIB Subcutaneous Missed Dose Study
NCT00533897 ·Status: COMPLETED ·Phase: PHASE3
-
Methotrexate-Inadequate Response Autoinjector Device Sub Study
NCT01844895 ·Status: COMPLETED ·Phase: PHASE3
-
Methotrexate-Inadequate Response Study
NCT00559585 ·Status: COMPLETED ·Phase: PHASE3
-
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
NCT02885818 ·Status: COMPLETED
-
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
NCT02805010 ·Status: UNKNOWN ·Phase: PHASE1
-
Abatacept With Methotrexate- Phase IIB
NCT00162266 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
NCT01960855 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
NCT03882008 ·Status: COMPLETED ·Phase: PHASE4
-
Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday
NCT01846975 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study
NCT02433340 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00048568 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
NCT01088360 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT02722694 ·Status: UNKNOWN ·Phase: PHASE3
-
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00122382 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
NCT00345748 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis
NCT02531178 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage
NCT01333878 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
NCT00124982 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone
NCT02066389 ·Status: COMPLETED ·Phase: PHASE2